AstraZeneca finally accelerates its cancer drug testing and soon the results will be out.

The drug maker has finally enrolled the first patient into its final-stage clinical trial of the new drug. The company hopes the success of the new drug trial, which seeks treatment for a rare type of leukemia.

Recently, the biopharmaceutical company Suven Life Sciences Limited has received three new patents that correspond to the new chemical entities (NCEs) for treating of disorders linked with neurodegenerative diseases.

On Tuesday, it was announced by Cubist Pharmaceuticals Inc. that its experimental antibiotic regimen was granted fast-track status by the US Food and Drug Administration as a cure for three different infections.

Finding the data to be inconsistent, an advisory panel to the Food and Drug Administration has asked the agency to reject Aveo Pharmaceuticals Inc. and Astellas Pharma Inc.'s kidney cancer drug.

Canadian generic drug manufacturer Apotex was being sent a warning letter from a U. S. regulator over quality control issues. The letter warned Apotex that the exports to the United States could be blocked if the company does not improve the overall quality of the products.

The US Government has alleged that Novartis Pharmaceuticals Corp has given bribe to pharmacies to encourage kidney transplant patients to switch from competitors' drugs to its own drug.

The government said Novartis has given bonus of several hundred thousand dollars to one of the pharmacists to switch patients to its drug Myfortic.